TXNRD2 Function and Biomarkers (G10587)

Target Name: TXNRD2

NCBI ID: G10587

TXNRD2

TXNRD2 Function and Biomarkers

TXNRD2 (thioredoxin reductase 2) is a gene that encodes a protein involved in the detoxification of environmental toxins, such as polychlorinated biphenyls (PCBs) and polycyclic aromatic hydrocarbons (PAHs). The encoded protein, TXNRD2, has been shown to play a crucial role in protecting against the toxic effects of these substances. Unfortunately, the high levels of these toxins can cause chronic health problems, including cancer, neurodegenerative diseases, and reproductive disorders. Therefore, identifying potential drug targets or biomarkers for TXNRD2 could have a significant impact on the development of new treatments for these diseases.

Diseases caused by TXNRD2 dysfunction

TXNRD2 is involved in the detoxification of environmental toxins, which are known to have a wide range of toxic effects. One of the most well-known toxins is PCBs, which are synthetic chemicals that have been used in products such as flame retardants, electrical equipment, and adhesives. PAHs, on the other hand, are also synthetic compounds that can be found in various products, including plastics, textiles, and consumer products. These toxins have been linked to a number of health problems, including cancer, neurodegenerative diseases, and reproductive disorders.

One of the factors that make these toxins so dangerous is their ability to accumulate in the body over time. These toxins can remain stored in fatty tissues, where they can cause chronic inflammation and damage. TXNRD2 is involved in the detoxification of these toxins, but when it does not function properly, it can lead to the buildup of these toxins in the body and the development of chronic health problems.

Drug targets for TXNRD2

TXNRD2 is a potential drug target because of its involvement in the detoxification of environmental toxins. Researchers have identified several potential drug targets for TXNRD2, including the interaction with nuclear factor kappa B (NFKB), the production of reactive oxygen species (ROS), and the detoxification of polychlorinated biphenyls (PCBs) and polycyclic aromatic hydrocarbons (PAHs).

The interaction between TXNRD2 and NFKB has been shown to play a role in the detoxification of environmental toxins. TXNRD2 has been shown to inhibit the activity of NFKB, which is a protein that plays a role in regulating inflammation and stress responses. This interaction between TXNRD2 and NFKB makes it a potential target for drugs that are designed to treat inflammatory and stress-related diseases.

The production of ROS by TXNRD2 has also been identified as a potential drug target. ROS are reactive oxygen species that can cause damage to cells and contribute to the development of a variety of diseases, including cancer. TXNRD2 has been shown to produce ROS, and the production of ROS has been linked to the development of cancer. Therefore, drugs that can inhibit the production of ROS by TXNRD2 may be a useful approach to treating cancer.

The detoxification of PCBs and PAHs is also an important function of TXNRD2. These toxins are known to cause a wide range of health problems, including cancer, neurodegenerative diseases, and reproductive disorders. Therefore, drugs that can aid in the detoxification of these toxins may be a valuable approach to treating these diseases.

Biomarkers for TXNRD2

TXNRD2 has been shown to play a crucial role in the detoxification of environmental toxins, and its dysfunction has been linked to the development of a wide range of chronic health problems. Therefore, identifying potential biomarkers for TXNRD2 may have a significant impact on the development of new treatments for these diseases.

One approach to identifying potential biomarkers for TXNRD2 is to use techniques such as mass spectrometry to identify changes in the expression of TXNRD2 genes that occur in response to the detoxification of environmental

Protein Name: Thioredoxin Reductase 2

Functions: Involved in the control of reactive oxygen species levels and the regulation of mitochondrial redox homeostasis (PubMed:24601690). Maintains thioredoxin in a reduced state. May play a role in redox-regulated cell signaling

The "TXNRD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TXNRD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets